CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 253 filers reported holding CUBIST PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $25,716,000 | +6187.5% | 255,500 | +4254.1% | 0.15% | +4933.3% |
Q2 2014 | $409,000 | -96.2% | 5,868 | -96.2% | 0.00% | -95.6% |
Q4 2013 | $10,699,000 | +34.5% | 155,355 | +24.2% | 0.07% | -12.8% |
Q3 2013 | $7,952,000 | +34.4% | 125,120 | +2.1% | 0.08% | +21.9% |
Q2 2013 | $5,916,000 | – | 122,495 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AKANTHOS CAPITAL MANAGEMENT LLC | 50,500 | $3,526,000 | 10.49% |
Palo Alto Investors LP | 1,526,916 | $106,609,000 | 7.94% |
HealthCor Management, L.P. | 1,225,000 | $85,530,000 | 4.29% |
SECTOR GAMMA AS | 192,490 | $13,440,000 | 3.18% |
AMI ASSET MANAGEMENT CORP | 363,698 | $25,393,000 | 2.52% |
EAGLE BOSTON INVESTMENT MANAGEMENT INC | 578,207 | $40,370,000 | 2.01% |
TURNER INVESTMENTS LLC | 559,239 | $39,046,000 | 1.73% |
Tekla Capital Management LLC | 263,772 | $18,417,000 | 1.69% |
MAZAMA CAPITAL MANAGEMENT INC | 80,221 | $5,601,000 | 1.50% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 3,234,570 | $225,838,000 | 1.34% |